SEARCH

SEARCH BY CITATION

References

  • APPERLEY, E., HUMPHREY, P.P.A. & LEVY, G.P. (1976). Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br. J. Pharmacol., 58, 211221.
  • APPERLEY, E., FENIUK, W., HUMPHREY, P.P.A. & LEVY, G.P. (1980). Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br. J. Pharmacol., 68, 215224.
  • BRADLEY, P.B., ENGEL, G., FENIUK, W., FOZARD, J.R., HUMPHREY, P.P.A., MIDDLEMISS, D.N., MYLECHARANE, E.J., RICHARDSON, B.P. & SAXENA, P.R. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology, 25, 563576.
  • BRITTAIN, R.T., BOUTAL, L., CARTER, M.C., COLEMAN, R.A., COLLINGTON, E.W., GEISOW, H.P., HALLETT, P., HORNBY, E.J., HUMPHREY, P.P.A., JACK, D., KENNEDY, I., LUMLEY, P., McCABE, P.J., SKIDMORE, I.F., THOMAS, M. & WALLIS, C.J. (1985). AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Circulation, 72, 12081218.
  • BRITTAIN, R.T., BUTINA, D., COATES, I.H., FENIUK, W., HUMPHREY, P.P.A., JACK, D., OXFORD, A.W. & PERREN, M.J. (1987). GR43175 selectively constricts the canine carotid arterial bed via stimulation of 5-HT1-like receptors. Br. J. Pharmacol., 91, 618P.
  • CHARLTON, K.G., BOND, R.A. & CLARKE, D.E. (1986). An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1c subtypes. Naunyn Schmiedebergs Arch. Pharmacol., 332, 815.
  • COCKS, T. & ANGUS, J.A. (1983). Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature, 305, 627630.
  • CONNOR, H.E., FENIUK, W., HUMPHREY, P.P.A. & PERREN, M.J. (1986). 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats. Br. J. Pharmacol., 87, 417426.
  • CONNOR, H.E., FENIUK, W. & HUMPHREY, P.P.A. (1987). Characterisation of 5-HT receptors mediating contraction in dog and primate isolated basilar artery. Br. J. Pharmacol., 92, 757P.
  • ENGEL, G., GOTHERT, M., MULLER-SCHWEINITZER, E., SCHLICKER, E., SISTONEN, L. & STADLER, P.A. (1983). Evidence for common pharmacological properties of [3H]-5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn Schmiedebergs Arch. Pharmacol., 24, 116124.
  • FENIUK, W., HUMPHREY, P.P.A. & WATTS, A.D. (1979). Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein. Br. J. Pharmacol., 67, 247254.
  • FENIUK, W., HUMPHREY, P.P.A. & WATTS, A.D. (1981). Further characterization of pre- and post-junctional receptors for 5-hydroxytryptamine in isolated vasculature. Br. J. Pharmacol., 73, 191P192P.
  • FENIUK, W., HUMPHREY, P.P.A. & WATTS, A.D. (1983). 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur. J. Pharmacol., 96, 7178.
  • FENIUK, W., HUMPHREY, P.P.A. & WATTS, A.D. (1984). 5-Cardoxamido-tryptamine — a potent agonist at 5-hydroxytryptamine receptors mediating relaxation. Br. J. Pharmacol., 82, 209P.
  • FENIUK, W., HUMPHREY, P.P.A., PERREN, M.J. & WATTS, A.D. (1985). A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br. J. Pharmacol., 86, 697704.
  • FENIUK, W., HUMPHREY, P.P.A. & PERREN, M.J. (1987). Selective vasoconstrictor action of GR43175 on arteriovenous anastomoses (AVAS) in the anaesthetised cat. Br. J. Pharmacol., 92, 756P.
  • HEURING, R.E. & PEROUTKA, S.J. (1987). Characterisation of a novel 3H-5-hydroxytryptamine binding site in bovine brain membranes. J. Neuroscience, 7, 894903.
  • HOYER, D., ENGEL, G. & KALKMAN, H.O. (1985). Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur. J. Pharmacol., 118, 1323.
  • HUMPHREY, P.P.A. & FENIUK, W. (1987). Pharmacological characterisation of functional neuronal receptors for 5-hydroxytryptamine. In Neuronal Messengers in Vascular Function ed. Nobin, A., Owman, C. & Arneklo-Nobin, B. pp. 319. Amsterdam: Elsevier Science Publishers.
  • HUMPHREY, P.P.A., FENIUK, W., PERREN, M.J., OXFORD, A.W., COATES, I.H., BUTINA, D., BRITTAIN, R.T. & JACK, D. (1987a). GR43175 — a selective agonist for functional 5-HT1-like receptors in dog saphenous vein. Br. J. Pharmacol., 92, 616P.
  • HUMPHREY, P.P.A., FENIUK, W., PERREN, M.J., OXFORD, A.W., BRITTAIN, R.T. & JACK, D. (1987b). The pharmacology of selective 5-HT1-like receptor agonists for the acute treatment of migraine. Cephalalgia, 7, 400401.
  • IRELAND, S.J. & TYERS, M.B. (1987). Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br. J. Pharmacol., 90, 229238.
  • KENAKIN, T.P. & BEEK, D. (1980). Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus response relationships. J. Pharmacol. Exp. Therap., 213, 406413.
  • MARTIN, G.R., LEFF, P., CAMBRIDGE, D. & BARRETT, V.J. (1987). Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn Schmiedebergs Arch. Pharmacol., 336, 365373.
  • MULLER-SCHWEINITZER, E. (1981). Agonist potencies of tryptamine derivatives at pre- and post-junctional receptors in canine saphenous vein. Postgrad. Med. J., 57, 3644.
  • SAXENA, P.R. & VERDOUW, P.D. (1985). 5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br. J. Pharmacol., 84, 533544.
  • TREVETHICK, M.A., FENIUK, W. & HUMPHREY, P.P.A. (1986). 5-Carboxamidotryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava. Life Sci., 38, 15211528.
  • VERDOUW, P.D., JENNEWEIN, H.M., MIERAU, J. & SAXENA, P.R. (1985). N-(3-acetylaminophenyl)piperazine hydrochloride (BEA 1654), a putative 5-HT1 agonist, causes constriction of arteriovenous anastomoses and dilatation of arterioles. Eur. J. Pharmacol., 107, 337346.
  • WATTS, A.D., FENIUK, W. & HUMPHREY, P.P.A. (1981). A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein. J. Pharm. Pharmacol., 33, 515520.